New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 30, 2012
09:59 EDTRY, WAC, LMT, CAG, BRO, ULTA, HMSY, CBM, KUB, STJ, DFT, ACTV, BELFBOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Active Network (ACTV) upgraded to Buy from Underperform at BofA/Merrill... Bel Fuse (BELFB) upgraded to Buy from Hold at Needham... Cambrex (CBM) upgraded to Buy from Neutral at Longbow... ConAgra (CAG) upgraded to Buy from Hold at Jefferies... DuPont Fabros (DFT) upgraded to Outperform from Sector Perform at RBC Capital... HMS Holdings (HMSY) upgraded to Buy from Hold at Jefferies... Lockheed Martin (LMT) upgraded to Fair Value from Sell at CRT Capital... St. Jude Medical (STJ) upgraded to Buy from Neutral at Mizuho... Ulta Salon (ULTA) upgraded to Outperform from Market Perform at Wells Fargo... Walter Investment (WAC) upgraded to Outperform from Market Perform at Keefe Bruyette... Kubota Limited (KUB) upgraded to Buy from Neutral at BofA/Merrill... Brown & Brown (BRO) upgraded to Outperform from Neutral at Macquarie... Royal Bank of Canada (RY) upgraded to Outperform from Neutral at Macquarie.
News For ACTV;BELFB;CBM;CAG;DFT;HMSY;LMT;STJ;ULTA;WAC;KUB;BRO;RY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
February 8, 2016
08:03 EDTSTJSt. Jude Medical announces launch of OPTIS mobile system in Europe, Japan
Subscribe for More Information
07:26 EDTSTJSt. Jude Medical upgraded to Hold from Sell at Canaccord
Subscribe for More Information
06:35 EDTBROBrown & Brown acquires Social Security disability insurance
Brown & Brown and Ann Marie Beaudoin and Victor Arruda, the founders of Social Security Advocates for the Disabled, or SSAD, announced that The Advocator Group, a subsidiary of Brown & Brown, has acquired substantially all of the equity interests of SSAD. will continue to operate from its offices in Norwell, Massachusetts, under the sales leadership of Ann Marie Beaudoin and operational leadership of Megan Reid. The SSAD operations will report to Julie Turpin, CEO of The Advocator Group.
February 5, 2016
17:02 EDTBROBrown & Brown acquires assets of Lumbermens Insurance
Subscribe for More Information
12:26 EDTULTAOptions with increasing implied volatility
Subscribe for More Information
February 4, 2016
13:40 EDTLMTAirbus: Still in talks with Poland over helicopter deliveries, Reuters reports
Airbus' (EADSY) helicopter unit said that discussions with Poland's economy ministry were continuing on the delivery of 50 helicopters for Poland's army, Reuters reports. Rzeczpospolita reported that Poland abandoned the $3B deal and agreed with the French defense ministry that it would purchase just "several" helicopter from Airbus, the report says. Poland has also initiated negotations with Lockheed Martin's (LMT) Skikorsky, the report says, citing Rzeczpospolita. Reference Link
07:14 EDTDFTDuPont Fabros sees Q1 FFO 66c-68c, consensus 64c
Subscribe for More Information
07:13 EDTDFTDuPont Fabros sees 2016 FFO $2.65-$2.85, consensus $2.68
Subscribe for More Information
07:08 EDTDFTDuPont Fabros repots Q4 FFO 61c, consensus 61c
Subscribe for More Information
06:22 EDTLMTPrivate space companies schedule jump in launches in 2016, Reuters says
Subscribe for More Information
February 3, 2016
06:18 EDTLMTPentagon plans to increase funding for Raytheon, Lockheed missiles, Reuters says
Subscribe for More Information
05:21 EDTLMTLockheed Martin awarded JCSAT-17 satellite contract from SKY Perfect JSAT
Subscribe for More Information
February 2, 2016
10:00 EDTDFTOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: DuPont Fabros (DFT) upgraded to Buy from Hold at Evercore ISI... GOL Linhas (GOL) upgraded to Neutral from Sell at Goldman... Integrated Device (IDTI) upgraded to Outperform from Neutral at Wedbush... Julius Baer (JBAXY) upgraded to Hold from Sell at Deutsche Bank... Kohl's (KSS) upgraded to Buy from Neutral at Buckingham... Mattel (MAT) upgraded on positive catalysts at Stifel... Mitsubishi sees limited downside for Tableau (DATA), ups to Neutral ... Morgan Stanley (MS) upgraded to Outperform from Neutral at Macquarie... Netflix (NFLX) upgraded to Overweight from Neutral at Piper Jaffray... Realty Income (O) upgraded to Equal Weight from Underweight at Morgan Stanley... TJX (TJX) upgraded to Outperform from Market Perform at BMO Capital.
05:33 EDTDFTDuPont Fabros upgraded to Buy from Hold at Evercore ISI
Subscribe for More Information
February 1, 2016
16:09 EDTCAGConAgra sees $1.6B tax asset from sale of private label operations to TreeHouse
ConAgra Foods announced the completion of the sale of its private label operations to TreeHouse Foods for proceeds of $2.7B in cash, excluding transaction-related expenses and subject to post-closing adjustments. A total of approximately 9,500 employees transitioned to TreeHouse Foods, including plant employees and those supporting the private label business located at the St. Louis, Mo., Downers Grove, Ill., and Omaha, Neb., office locations. Certain private label operations with a strong connection to ConAgra Foods' existing Consumer Foods business were not part of the sale, specifically canned pasta, cooking spray, peanut butter, pudding/gels, Gelit frozen pasta product offerings, as well as the HK Anderson and Kangaroo brand equities, trademarks and business portfolios. Results for these operations, which were not material, were moved to the Consumer Foods reporting segment in Q1. ConAgra Foods generated approximately $2.7B in cash proceeds from the sale, less transaction expenses, and intends to utilize the net proceeds primarily for debt reduction. The company expects the transaction to result in a tax asset of approximately $1.6B, which can be used to offset potential future capital gains over the next five years.
10:06 EDTLMTLockheed Martin and Duke Energy sign 17-year energy agreement
Subscribe for More Information
January 29, 2016
09:23 EDTLMTLockheed Martin weakness creates buying opportunity, says Argus
Subscribe for More Information
06:38 EDTWACWalter Investment announces acquisition of certain assets from RCS
Subscribe for More Information
January 28, 2016
18:41 EDTLMTLockheed Martin awarded $198.73M government contract modification
Subscribe for More Information
11:11 EDTSTJHeartWare rallies after scrapping Valtech acquisition
The shares of HeartWare (HTWR) are surging after the company announced that would terminate its acquisition of privately held Valtech. Two research firms reacted positively to the news, with Leerink Swann saying that the company made the right decision, given its current difficulties and Raymond James upgrading HeartWare following the news. HeartWare develops and manufactures miniaturized implantable heart pumps, while Valtech has developed a method of replacing mitral valves in human hearts without the need for open heart surgery. WHAT'S NEW: HeartWare decided to terminate its acquisition of Valtech, the companies announced this morning. Pursuant to the terms of the agreement, HeartWare will make a $30M loan to Valtech in the form of a convertible promissory note. ANALYST REACTION: HeartWare's decision to abandon its acquisition of Valtech was correct in light of the problems that the company is facing with its next generation MVAD pump, Leerink analyst Danielle Antalffy wrote in a note to investors today. Noting that two weeks ago HeartWare announced that it would investigate suction issues that the device has had, the analyst says that fixing the pump could require additional investment, while it's uncertain how long it will take to solve the device's problems. However, the analyst remained upbeat on Heartware's current LVAD products, and believes that it can compete with next generation systems. She kept a $60 price target and Outperform rating on the shares. Raymond James upgraded HeartWare to Outperform from Market Perform, saying that the termination of the Valtech deal removes an overhang on the shares, while the stock's underperformance since September has made its valuation more attractive. Moreover, the stock does not appear to be giving any value to the problematic MVAD pump and the company has a 37% share of a $760M market that has only two main competitors and high barriers to entry, the firm wrote. WHAT'S NOTABLE: In early October 2015, activist investor Engaged Capital urged HeartWare to terminate the Valtech deal. Today HeartWare announced that it would, in conjunction with Engaged Capital, "jointly select" an independent party who will join Heartware's board. ANOTHER TO WATCH: HeartWare's chief rival, Thoratec, was acquired last year by St. Jude Medical (STJ). PRICE ACTION: In late morning trading, HeartWare rose 10% to $37.95. St. Jude, which reported its fourth quarter results and gave fiscal year guidance this morning, is down 1.4% to $53.56.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use